| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 135, 484-487, Copyright © 1994 by Endocrine Society
ARTICLES |
H Kaji, T Sugimoto, A Miyauchi, M Fukase, K Tezuka, Y Hakeda, M Kumegawa and K Chihara
Department of Medicine, Kobe University School of Medicine, Japan.
Recent evidence indicates that osteopontin (Opn), one of the bone matrix proteins, plays an important role in the attachment of osteoclasts to bone matrix. Besides being elaborated by osteoblasts, this protein is also produced by osteoclasts. The present study was performed to examine the effect of calcitonin (CT) on Opn mRNA expression of isolated rabbit osteoclasts and to clarify the second messenger signaling of this effect. Eel CT inhibited Opn mRNA expression as well as bone-resorbing activity of isolated rabbit osteoclasts. Eel CT caused a transient increase in intracellular calcium followed by a sustained increase as well as an increase in cAMP production in these cells. Dibutyryl-cAMP (10(-4) M) and Sp-cAMPS (10(- 4) M), an activator of cAMP-dependent protein kinase (PKA), as well as A23187 (10(-7) M), a calcium ionophore, and phorbol myristate acetate (10(-7) M), an activator of protein kinase C (PKC), caused a significant inhibition of Opn mRNA expression, and suppressed bone- resorbing activity of isolated osteoclasts. The present study is the first to demonstrate that CT inhibits Opn mRNA expression in isolated rabbit osteoclasts, presumably through the activation of PKA and calcium/PKC pathways, by which the bone-resorbing activity might be attenuated subsequently.
This article has been cited by other articles:
![]() |
K. Fuller, B. Kirstein, and T. J. Chambers Murine Osteoclast Formation and Function: Differential Regulation by Humoral Agents Endocrinology, April 1, 2006; 147(4): 1979 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Boissy, F. Saltel, C. Bouniol, P. Jurdic, and I. Machuca-Gayet Transcriptional Activity of Nuclei in Multinucleated Osteoclasts and Its Modulation by Calcitonin Endocrinology, May 1, 2002; 143(5): 1913 - 1921. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Asou, S. R. Rittling, H. Yoshitake, K. Tsuji, K. Shinomiya, A. Nifuji, D. T. Denhardt, and M. Noda Osteopontin Facilitates Angiogenesis, Accumulation of Osteoclasts, and Resorption in Ectopic Bone Endocrinology, March 1, 2001; 142(3): 1325 - 1332. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sodek, B. Ganss, and M.D. McKee Osteopontin Critical Reviews in Oral Biology & Medicine, January 1, 2000; 11(3): 279 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Sato, M del Carmen Ovejero, P Hou, A. Heegaard, M Kumegawa, N. Foged, and J. Delaisse Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts J. Cell Sci., January 3, 1997; 110(5): 589 - 596. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |